Quantitative metabolomics services for biomarker discovery and validation.
Specializing in ready to use metabolomics kits.
Your source for quantitative metabolomics technologies and bioinformatics.
Loader

Filter by Pathway Type:



Showing 661 - 670 of 605359 pathways
SMPDB ID Pathway Name and Description Pathway Class Chemical Compounds Proteins

SMP0000695

Pw000672 View Pathway

Etoricoxib Action Pathway

Etoricoxib (also named as Arcoxia) is a COX-2 selective inhibitor. It can be used to treat fever, pain, swelling, inflammation, and platelet aggregation. Etoricoxib can block prostaglandin synthesis by the action of inhibition of prostaglandin G/H synthase 1 and 2. Prostaglandin G/H synthase 1 and 2 catalyze the arachidonic acid to prostaglandin G2, and also catalyze prostaglandin G2 to prostaglandin H2 in the metabolism pathway.
Drug Action

SMP0000696

Pw000673 View Pathway

Fenoprofen Action Pathway

Fenoprofen (also named Nalfon) is a nonsteroidal anti-inflammatory drug. Fenoprofen can block prostaglandin synthesis by the action of inhibition of prostaglandin G/H synthase 1 and 2. Prostaglandin G/H synthase 1 and 2 catalyze the arachidonic acid to prostaglandin G2, and also catalyze prostaglandin G2 to prostaglandin H2 in the metabolism pathway. Decreased prostaglandin synthesis in many animal model's cell is caused by presence of Fenoprofen.
Drug Action

SMP0000697

Pw000674 View Pathway

Flurbiprofen Action Pathway

Flurbiprofen (also named Ansaid or Froben) is a nonsteroidal anti-inflammatory drugs. It is used for treatment of moderate pain. Flurbiprofen can block prostaglandin synthesis by the action of inhibition of prostaglandin G/H synthase 1 and 2. Prostaglandin G/H synthase 1 and 2 catalyze the arachidonic acid to prostaglandin G2, and also catalyze prostaglandin G2 to prostaglandin H2 in the metabolism pathway. Decreased prostaglandin synthesis in many animal model's cell is caused by presence of flurbiprofen.
Drug Action

SMP0000698

Pw000675 View Pathway

Magnesium Salicylate Action Pathway

Magnesium Salicylate is a nonsteroidal anti-inflammatory drug. It can be used to treat mild to moderate muscular pain such as headaches, general back pain and other joint pain. Magnesium Salicylate can block prostaglandin synthesis by the action of inhibition of prostaglandin G/H synthase 1 and 2. Prostaglandin G/H synthase 1 and 2 catalyze the arachidonic acid to prostaglandin G2, and also catalyze prostaglandin G2 to prostaglandin H2 in the metabolism pathway. Decreased prostaglandin synthesis in many animal model's cell is caused by presence of Magnesium Salicylate.
Drug Action

SMP0000699

Pw000676 View Pathway

Lumiracoxib Action Pathway

Lumiracoxib (also named Prexige) is a nonsteroidal anti-inflammatory drug (NSAID). It can be used as the mediators of certain kinds of intraocular inflammation. Lumiracoxib can block prostaglandin synthesis by the action of inhibition of prostaglandin G/H synthase 1 and 2. Prostaglandin G/H synthase 1 and 2 catalyze the arachidonic acid to prostaglandin G2, and also catalyze prostaglandin G2 to prostaglandin H2 in the metabolism pathway.
Drug Action

SMP0000700

Pw000677 View Pathway

Lornoxicam Action Pathway

Lornoxicam (also named Chlortenoxicam or Xefocam) is a nonsteroidal anti-inflammatory drug. It can be used to treat moderate pain such as pain relieving. It can also treat swelling and fever reducing. Lornoxicam can block prostaglandin synthesis by the action of inhibition of prostaglandin G/H synthase 1 and 2. Prostaglandin G/H synthase 1 and 2 catalyze the arachidonic acid to prostaglandin G2, and also catalyze prostaglandin G2 to prostaglandin H2 in the metabolism pathway. Decreased prostaglandin synthesis in many animal model's cell is caused by presence of Lornoxicam.
Drug Action

SMP0000701

Pw000678 View Pathway

Phenylbutazone Action Pathway

Phenylbutazone (also named fenilbutazona or butazolidin or bute) is a nonsteroidal anti-inflammatory drug (NSAID). It can be used to treat the pain and fever in animal. However, Phenylbutazone is not approved in United State and United Kingdom for human use anymore because of severe adverse effects. Phenylbutazone can block prostaglandin synthesis by the action of inhibition of prostaglandin G/H synthase 1 and 2. Prostaglandin G/H synthase 1 and 2 catalyze the arachidonic acid to prostaglandin G2, and also catalyze prostaglandin G2 to prostaglandin H2 in the metabolism pathway. Decreased prostaglandin synthesis in many animal model's cell is caused by presence of phenylbutazone.
Drug Action

SMP0000702

Pw000679 View Pathway

Nepafenac Action Pathway

Nepafenac (also named nevanac or ilevro or amfenac amide) is a nonsteroidal anti-inflammatory drug (NSAID). It can be used to treat pain and inflammation that is associated with cataract surgery. Nepafenac can block prostaglandin synthesis by the action of inhibition of prostaglandin G/H synthase 1 and 2. Prostaglandin G/H synthase 1 and 2 catalyze the arachidonic acid to prostaglandin G2, and also catalyze prostaglandin G2 to prostaglandin H2 in the metabolism pathway. Decreased prostaglandin synthesis in many animal model's cell is caused by presence of nepafenac.
Drug Action

SMP0000703

Pw000680 View Pathway

Trisalicylate-Choline Action Pathway

Trisalicylate-Choline (also named Choline Magnesium Trisalicylate) is a nonsteroidal anti-inflammatory drug (NSAID). It can be used to treat pain and fever. Trisalicylate-Choline can block prostaglandin synthesis by the action of inhibition of prostaglandin G/H synthase 1 and 2. Prostaglandin G/H synthase 1 and 2 catalyze the arachidonic acid to prostaglandin G2, and also catalyze prostaglandin G2 to prostaglandin H2 in the metabolism pathway. Decreased prostaglandin synthesis in many animal model's cell is caused by presence of trisalicylate-choline.
Drug Action

SMP0000704

Pw000681 View Pathway

Tolmetin Action Pathway

Tolmetin (also named Tolectin) is a nonsteroidal anti-inflammatory drug (NSAID). It can be used to reduce pain, swelling, tenderness, and stiffness. Tolmetin can block prostaglandin synthesis by the action of inhibition of prostaglandin G/H synthase 1 and 2. Prostaglandin G/H synthase 1 and 2 catalyze the arachidonic acid to prostaglandin G2, and also catalyze prostaglandin G2 to prostaglandin H2 in the metabolism pathway. Decreased prostaglandin synthesis in many animal model's cell is caused by presence of tolmetin.
Drug Action
Showing 661 - 670 of 65006 pathways